Literature DB >> 28506366

Antibody-Mediated Rejection After Liver Transplant.

Michael Lee1.   

Abstract

Antibody-mediated rejection (AMR) in liver transplants is a field in its infancy compared with its allograft cohorts of the kidney and lung. Acute AMR is diagnosed based on specific clinical and histopathologic criteria: serum donor specific antibodies, C4d staining, histopathologic findings on liver biopsy, and exclusion of other entities. In contrast, the histologic features of chronic AMR are not as specific and it is a more challenging diagnosis to make. Treatments of acute and chronic AMR include some combination of steroids, immune-modulating agents, intravenous immunoglobulin, plasmapheresis, and proteasome inhibitors.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibody-mediated rejection; Liver; Transplant

Mesh：

Substances：

Year:  2017        PMID： 28506366     DOI： 10.1016/j.gtc.2017.01.005

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN： 0889-8553            Impact factor:   3.806


  8 in total

1.  Lessons learnt from living donor liver transplantation with ABO-incompatibility: A single-centre experience from southern India.

Authors:  Surumi Shajahan; Sreedurga Thottanchery Sasidharan; Sudhindran Surendran; Veena Shenoy; Uma Devi Padma
Journal:  Indian J Gastroenterol       Date:  2019-03-08

2.  LncRNA Snhg1 Plays an Important Role via Sequestering rno-miR-139-5p to Function as a ceRNA in Acute Rejection After Rat Liver Transplantation Based on the Bioinformatics Analysis.

Authors:  Wu Wu; Menghao Wang; Chunming Li; Zhu Zhu; Yang Zhang; Di Wu; Zhibing Ou; Zuojin Liu
Journal:  Front Genet       Date:  2022-06-02       Impact factor: 4.772

3.  Liver Transplantation in Patients with Sickle Cell Disease in the United States.

Authors:  Rachel Hogen; Michelle Kim; Yelim Lee; Mary Lo; Navpreet Kaur; Jeff Kahn; Shefali Chopra; Yasir Qazi; Ashraf Sedra; Jim Kim; Lauren O'Brien; Yuri Genyk; Linda Sher; Juliet Emamaullee
Journal:  J Surg Res       Date:  2020-06-12       Impact factor: 2.192

4.  Acute liver failure secondary to acute antibody mediated rejection after compatible liver transplant: A case report.

Authors:  Todd J Robinson; James B Hendele; Idoia Gimferrer; Nicolae Leca; Scott W Biggins; Jorge D Reyes; Lena Sibulesky
Journal:  World J Hepatol       Date:  2022-01-27

Review 5.  Memory B cells and long-lived plasma cells in AMR.

Authors:  Wenlong Yue; Jia Liu; Xiaohu Li; Luman Wang; Jinfeng Li
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

6.  Donor-recipient human leukocyte antigen A mismatching is associated with hepatic artery thrombosis, sepsis, graft loss, and reduced survival after liver transplant.

Authors:  Christopher Bricogne; Neil Halliday; Raymond Fernando; Emmanuel A Tsochatzis; Brian R Davidson; Mark Harber; Rachel H Westbrook
Journal:  Liver Transpl       Date:  2022-05-04       Impact factor: 6.112

7.  Influence of Preformed Antibodies in Liver Transplantation.

Authors:  Isabel Legaz; Francisco Boix; Manuela López; Rafael Alfaro; José A Galián; Santiago Llorente; Jose A Campillo; Carmen Botella; Pablo Ramírez; Francisco Sánchez-Bueno; José A Pons; María R Moya-Quiles; Alfredo Minguela; Manuel Muro
Journal:  J Clin Med       Date:  2020-03-05       Impact factor: 4.241

Review 8.  The role of the gut microbiome in graft fibrosis after pediatric liver transplantation.

Authors:  Tian Qin; Jingyuan Fu; Henkjan J Verkade
Journal:  Hum Genet       Date:  2020-09-13       Impact factor: 4.132
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.